Reduced ING4 expression is associated with the malignancy of human bladder

Urologia Internationalis

Volumn 94, Issue 4, 2015, Pages 464-471

  Wang, Yongquan ^a   Wang, Tianying ^a   Han, Yelu ^a   Wu, Heng ^a   Zhao, Wenran ^a   Tong, Dandan ^a   Wei, Lanlan ^a   Zhong, Zhaohua ^a   An, Ruihua ^a   Wang, Yan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Cell cycle; Cell migration; Human bladder; Inhibitor of growth 4

Indexed keywords

GROWTH INHIBITOR; INHIBITOR OF GROWTH 4; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; HOMEODOMAIN PROTEIN; ING4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; BLADDER CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BLADDER TUMOR; CELL MOTION; CELL PROLIFERATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TIME; TUMOR CELL LINE; TUMOR INVASION;

AGED; BIOMARKERS, TUMOR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 84930575274     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000364832     Document Type: Article

References (38)

1. Piche B, Li G: Inhibitor of growth tumor suppressors in cancer progression. Cell Mol Life Sci 2010; 67: 1987-1999.
2. Gunduz M, Nagatsuka H, Demircan K, Gunduz E, Cengiz B, Ouchida M, Tsujigiwa H, Yamachika E, Fukushima K, Beder L, Hirohata S, Ninomiya Y, Nishizaki K, Shimizu K, Nagai N: Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005; 356: 109-117.
3. Mathema VB, Koh YS: Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity. Tumour Biol 2012; 33: 1-7.
4. Wang QS, Li M, Zhang LY, Jin Y, Tong DD, Yu Y, Bai J, Huang Q, Liu FL, Liu A, Lee KY, Fu SB: Down-regulation of ING4 is associated with initiation and progression of lung cancer. Histopathology 2010; 57: 271-281.
5. Xie Y, Zhang H, Sheng W, Xiang J, Ye Z, Yang J: Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett 2008; 271: 105-116.
6. Cai L, Li X, Zheng S, Wang Y, Li H, Yang J, Sun J: Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14. Melanoma Res 2009; 19: 1-7.
7. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428: 328-332.
8. Russell M, Berardi P, Gong W, Riabowol K: Grow-ING, age-ING and die-ING: ING proteins link cancer, senescence and apoptosis. Exp Cell Res 2006; 312: 951-961.
9. Saha A, Bamidele A, Murakami M, Robertson ES: EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5. J Virol 2011; 85: 2079-2088.
10. Zhang X, Wang KS, Wang ZQ, Xu LS, Wang QW, Chen F, Wei DZ, Han ZG: Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem Biophys Res Commun 2005; 331: 1032-1038.
11. Guo Q, Fast W: Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. J Biol Chem 2011; 286: 17069-17078.
12. Soliman MA, Riabowol K: After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci 2007; 32: 509-519.
13. Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC: p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 2003; 63: 2373-2378.
14. Coles AH, Gannon H, Cerny A, Kurt-Jones E, Jones SN: Inhibitor of growth-4 promotes IκB promoter activation to suppress NF-κB signaling and innate immunity. Proc Natl Acad Sci USA 2010; 107: 11423-11428.
15. Kim S, Chin K, Gray JW, Bishop JM: A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 2004; 101: 16251-16256.
16. Ozer A, Bruick RK: Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell Cycle 2005; 4: 1153-1156.
17. Ozer A, Wu LC, Bruick RK: The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor. Proc Natl Acad Sci USA 2005; 102: 7481-7486.
18. Zhang X, Lin DH, Jin Y, Wang KS, Zhang Y, Babilonia E, Wang Z, Giebisch G, Han ZG, Wang WH: Inhibitor of growth 4 (ING4) is upregulated by a low K intake and suppresses renal outer medullary K channels (ROMK) by MAPK stimulation. Proc Natl Acad Sci USA 2007; 104: 9517-9522.
19. Zhang X, Xu LS, Wang ZQ, Wang KS, Li N, Cheng ZH, Huang SZ, Wei DZ, Han ZG: ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett 2004; 570: 7-12.
20. Brat DJ, Bellail AC, Van Meir EG: The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 2005; 7: 122-133.
21. Cai L, Li X, Zheng S, Wang Y, Wang Y, Li H, Yang J, Sun J: Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14. Melanoma Res 2009; 19: 1-7.
22. Li M, Jin Y, Sun WJ, Yu Y, Bai J, Tong DD, Qi JP, Du JR, Geng JS, Huang Q, Huang XY, Huang Y, Han FF, Meng XN, Rosales JL, Lee KY, Fu SB: Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J Pathol 2009; 219: 87-95.
23. Tapia C, Zlobec I, Schneider S, Kilic E, Guth U, Bubendorf L, Kim S: Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer. Hum Pathol 2011; 42: 983-990.
24. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA: The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89: 630-639.
25. Ploeg M, Aben KKH, Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-293.
26. Vishnu P, Mathew J, Tan WW: Current therapeutic strategies for invasive and metastatic bladder cancer. Onco Targets Ther 2011; 4: 97-113.
27. Zhang ZG, Ouyang J, Han CH, Yang JC, Yang HC, Long JH, Ding X: Growth inhibition and mechanisms of human bladder cancer T24 cells by adenovirus-mediated ING4 gene in vitro. Zhonghua Yi Xue Za Zhi 2010; 90: 3008-3013.
28. Grignon DJ: The current classification of urothelial neoplasms. Mod Pathol 2009; 22(suppl 2):S60-S69.
29. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 -ΔΔCT method. Methods 2001; 25: 402-408.
30. Shen JC, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K, Pedeux R, Harris CC: Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin α1. Cancer Res 2007; 67: 2552-2558.
31. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000; 100: 57-70.
32. Xie YF, Sheng W, Xiang J, Zhang H, Ye Z, Yang J: Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis. Cancer Biother Radiopharm 2009; 24: 261-269.
33. Borkosky SS, Gunduz M, Beder L, Tsujigiwa H, Tamamura R, Gunduz E, Katase N, Rodriguez AP, Sasaki A, Nagai N, Nagatsuka H: Allelic loss of the ING gene family loci is a frequent event in ameloblastoma. Oncol Res 2010; 18: 509-518.
34. Fang F, Luo LB, Tao YM, Wu F, Yang LY: Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2009; 18: 409-416.
35. Li Z, Xie Y, Sheng W, Miao J, Xiang J, Yang J: Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo. Cancer Biother Radiopharm 2010; 25: 427-437.
36. Doyon Y, Cayrou C, Ullah M, Landry AJ, Cote V, Selleck W, Lane WS, Tan S, Yang XJ, Cote J: ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006; 21: 51-64.
37. Saksouk N, Avvakumov N, Champagne KS, Hung T, Doyon Y, Cayrou C, Paquet E, Ullah M, Landry AJ, Cote V, Yang XJ, Gozani O, Kutateladze TG, Cote J: HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol Cell 2009; 33: 257-265.
38. Wei Q, He W, Lu Y, Yao J, Cao X: Effect of the tumor suppressor gene ING4 on the proliferation of MCF-7 human breast cancer cells. Oncol Lett 2012; 4: 438-442.